| Globe Life | 100.0 | 4 | 3 |
| Equitable Holdings | 83.4 | 3 | 2 |
| Primerica | 81.0 | 2 | 3 |
| The Cigna Group | 71.7 | 3 | 1 |
| Sproutt Insurance | 71.7 | 3 | 1 |
| Western & Southern Financial Group | 61.0 | 2 | 1 |
| Insular Life | 61.0 | 2 | 1 |
| Lemonade | 61.0 | 2 | 1 |
| Choice Mutual | 61.0 | 2 | 1 |
| Lincoln National Corporation | 57.5 | 1 | 2 |
| State Farm Insurance | 51.7 | 3 | 0 |
| MetLife | 45.8 | 1 | 1 |
| New York Life Insurance Company | 45.8 | 1 | 1 |
| Northwestern Mutual | 45.8 | 1 | 1 |
| Prudential Financial | 45.8 | 1 | 1 |
| Guardian Life Insurance Company of America | 45.8 | 1 | 1 |
| Massachusetts Mutual Life Insurance Company | 45.8 | 1 | 1 |
| Colonial Penn | 45.8 | 1 | 1 |
| Fidelity & Guaranty Life | 45.8 | 1 | 1 |
| Gerber Life Insurance Company | 45.8 | 1 | 1 |
| Assurity Life Insurance Company | 45.8 | 1 | 1 |
| Connecticut General Life Insurance Company | 45.8 | 1 | 1 |
| Ethos | 45.8 | 1 | 1 |
| U.S. News & World Report | 41.0 | 2 | 0 |
| Fidelity Investments | 41.0 | 2 | 0 |
| Transamerica Corporation | 41.0 | 2 | 0 |
| Lincoln Aviator | 41.0 | 2 | 0 |
| Lincoln MKX | 41.0 | 2 | 0 |
| Principal Financial Group | 41.0 | 2 | 0 |
| Voya Financial | 41.0 | 2 | 0 |
| NerdWallet.com | 41.0 | 2 | 0 |
| Santa Barbara Independent | 41.0 | 2 | 0 |
| Trustpilot | 41.0 | 2 | 0 |
| MarketWatch | 41.0 | 2 | 0 |
| U.S. News & World Report Best Colleges Ranking | 41.0 | 2 | 0 |
| Forbes 30 Under 30 | 41.0 | 2 | 0 |
| Policygenius | 41.0 | 2 | 0 |
| Forbes ASAP | 41.0 | 2 | 0 |
| SelectQuote | 41.0 | 2 | 0 |
| Forbes Best-In-State Wealth Advisor | 41.0 | 2 | 0 |
| Forbes Top 250 Wealth Advisor | 41.0 | 2 | 0 |
| Bipartisan Patient Protection Act of 2001 | 41.0 | 2 | 0 |
| Insuranceopedia | 41.0 | 2 | 0 |
| Viatical settlement | 40.0 | 0 | 3 |
| whole life insurance | 40.0 | 0 | 3 |
| term life insurance | 31.7 | 0 | 2 |
| A. Maceo Walker | 31.7 | 0 | 2 |
| American Income Life Insurance Company | 31.7 | 0 | 2 |
| Corporate-owned life insurance | 31.7 | 0 | 2 |
| ICICI Prudential | 31.7 | 0 | 2 |
| Indexed universal life | 31.7 | 0 | 2 |
| Private placement life insurance | 31.7 | 0 | 2 |
| Universal life insurance | 31.7 | 0 | 2 |
| variable universal life insurance | 31.7 | 0 | 2 |
| with-profits policy | 31.7 | 0 | 2 |
| Term life insurance | 31.7 | 0 | 2 |
| Fair valuation of universal life policies via a replicating portfolio | 31.7 | 0 | 2 |
| Influence of a family history of type 2 diabetes, demographic and clinical data on carotid intima-media thickness in patients with type 1 diabetes: a cross-sectional study | 31.7 | 0 | 2 |
| Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood | 31.7 | 0 | 2 |
| Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes | 31.7 | 0 | 2 |
| Italian pediatric data support hypothesis that simultaneous epidemics of type 1 diabetes and type 2 diabetes/metabolic syndrome/obesity are polar opposite responses (i.e., symptoms) to a primary inflammatory condition | 31.7 | 0 | 2 |
| Adaptations leading to hypoglycaemia in type 1 diabetes mellitus and comparison with type 2 diabetes mellitus | 31.7 | 0 | 2 |
| Distinguishing type 2 diabetes from type 1 diabetes in African American and Hispanic American pediatric patients | 31.7 | 0 | 2 |
| Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes | 31.7 | 0 | 2 |
| Do your pediatric patients have chronic health conditions? Medical history responses may not be accurate | 31.7 | 0 | 2 |
| A humoral immune defect distinguishes the response to Staphylococcus aureus infections in mice with obesity and type 2 diabetes from that in mice with type 1 diabetes | 31.7 | 0 | 2 |
| Analysis of accelerated death benefit claims at a Japanese life insurance company. | 31.7 | 0 | 2 |
| Childhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton-lipid research clinics follow-up study. | 31.7 | 0 | 2 |
| Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases | 31.7 | 0 | 2 |
| Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects | 31.7 | 0 | 2 |
| Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice | 31.7 | 0 | 2 |
| Genetic predisposition to high blood pressure associates with cardiovascular complications among patients with type 2 diabetes: two independent studies | 31.7 | 0 | 2 |
| Collecting Family Health History using an Online Social Network: a Nationwide Survey among Potential Users | 31.7 | 0 | 2 |
| Association analysis of type 2 diabetes Loci in type 1 diabetes. | 31.7 | 0 | 2 |
| Effect of parental type 2 diabetes on offspring with type 1 diabetes | 31.7 | 0 | 2 |
| Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes | 31.7 | 0 | 2 |
| Family history of type 2 diabetes is increased in patients with type 1 diabetes | 31.7 | 0 | 2 |
| Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes | 31.7 | 0 | 2 |
| No association of multiple type 2 diabetes loci with type 1 diabetes | 31.7 | 0 | 2 |
| The 14 bp Del/Ins HLA-G polymorphism is related with high blood pressure in acute coronary syndrome and type 2 diabetes mellitus. | 31.7 | 0 | 2 |
| Overweight adolescents with type 2 diabetes have significantly higher lipoprotein abnormalities than those with type 1 diabetes | 31.7 | 0 | 2 |
| Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected]. | 31.7 | 0 | 2 |
| Barriers to glycemic control in youth with type 1 diabetes and type 2 diabetes | 31.7 | 0 | 2 |
| Translation of Family Health History Questions on Cardiovascular Disease and Type 2 Diabetes with Implications for Latina Health and Nursing Practice | 31.7 | 0 | 2 |
| Review of Evidence that Epidemics of Type 1 Diabetes and Type 2 Diabetes/ Metabolic Syndrome are Polar Opposite Responses to Iatrogenic Inflammation | 31.7 | 0 | 2 |
| Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure | 31.7 | 0 | 2 |
| Overlap of genetic susceptibility to type 1 diabetes, type 2 diabetes, and latent autoimmune diabetes in adults. | 31.7 | 0 | 2 |
| Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now? | 31.7 | 0 | 2 |
| Transcriptome meta-analysis of peripheral lymphomononuclear cells indicates that gestational diabetes is closer to type 1 diabetes than to type 2 diabetes mellitus | 31.7 | 0 | 2 |
| The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus. | 31.7 | 0 | 2 |
| Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes | 31.7 | 0 | 2 |
| Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes | 31.7 | 0 | 2 |
| Update on Management of Type 1 Diabetes and Type 2 Diabetes in Athletes | 31.7 | 0 | 2 |
| Frequency of anomalies in male applicants for whole life insurance | 31.7 | 0 | 2 |
| Ethnobotanical survey of medicinal plants used to manage High Blood Pressure and Type 2 Diabetes Mellitus in Bitterfontein, Western Cape Province, South Africa | 31.7 | 0 | 2 |
| Time Dependent Relative Risks in Life Insurance Medical Underwriting | 31.7 | 0 | 2 |
| Type 1 diabetes versus type 2 diabetes with onset in persons younger than 20 years of age. | 31.7 | 0 | 2 |
| Youth with type 1 diabetes have worse strain and less pronounced sex differences in early echocardiographic markers of diabetic cardiomyopathy compared to their normoglycemic peers: A RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) S | 31.7 | 0 | 2 |
| Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis. | 31.7 | 0 | 2 |
| Mental health issues in adolescents and young adults with type 1 diabetes: prevalence and impact on glycemic control. | 31.7 | 0 | 2 |
| The Role of Laboratory Testing in Differentiating Type 1 Diabetes from Type 2 Diabetes in Patients Undergoing Bariatric Surgery | 31.7 | 0 | 2 |
| High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia | 31.7 | 0 | 2 |
| Use of the 9-Item Patient Health Questionnaire for Depression Assessment in Primary Care Patients With Type 2 Diabetes | 31.7 | 0 | 2 |
| The Patient Health Questionnaire-9 as a Screening Tool for Depression in Individuals with Type 2 Diabetes Mellitus: The Maastricht Study | 31.7 | 0 | 2 |
| Term life insurance? | 31.7 | 0 | 2 |
| A description of clinician reported diagnosis of type 2 diabetes and other non-type 1 diabetes included in a large international multicentered pediatric diabetes registry (SWEET). | 31.7 | 0 | 2 |
| A Health Literacy Program Using Family Health History for Young Black Rural Students: Implications for Reducing Health Disparities | 31.7 | 0 | 2 |
| Impact of Genetic Testing and Family Health History Based Risk Counseling on Behavior Change and Cognitive Precursors for Type 2 Diabetes | 31.7 | 0 | 2 |
| Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes | 31.7 | 0 | 2 |
| Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study. | 31.7 | 0 | 2 |
| Age dependent decline of relative risks in life insurance medical underwriting | 31.7 | 0 | 2 |
| Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes | 31.7 | 0 | 2 |
| Is it time to challenge the established theories surrounding type 1 diabetes? | 31.7 | 0 | 2 |
| A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults | 31.7 | 0 | 2 |
| Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date | 31.7 | 0 | 2 |
| Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction | 31.7 | 0 | 2 |
| Serum 1,5-anhydroglucitol levels in patients with fulminant type 1 diabetes are lower than those in patients with type 2 diabetes | 31.7 | 0 | 2 |
| Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study | 31.7 | 0 | 2 |
| Serum glycated albumin to haemoglobin A(1C) ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus | 31.7 | 0 | 2 |
| AVMA life insurance policies | 31.7 | 0 | 2 |
| Postprandial blood glucose latency after oatmeal is a valid screening test for diabetic gastropathy in type 1 diabetes, but not in type 2 diabetes | 31.7 | 0 | 2 |
| Obesity, type 2 diabetes and high blood pressure amongst recently arrived Sudanese refugees in Queensland, Australia. | 31.7 | 0 | 2 |
| Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetes | 31.7 | 0 | 2 |
| Insulin administration may trigger type 1 diabetes in Japanese type 2 diabetes patients with type 1 diabetes high-risk HLA class II and the insulin gene VNTR genotype | 31.7 | 0 | 2 |
| C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus | 31.7 | 0 | 2 |
| Fulminant type 1 diabetes in an elderly patient treated after receiving a diagnosis of type 2 diabetes | 31.7 | 0 | 2 |
| Reporting diet-related health issues through newspapers: portrayal of cardiovascular disease and Type 2 diabetes | 31.7 | 0 | 2 |
| Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes | 31.7 | 0 | 2 |
| Treating high blood pressure in Africans with type 2 diabetes. | 31.7 | 0 | 2 |
| The effect of type 2 diabetes risk loci on insulin requirements in type 1 diabetes | 31.7 | 0 | 2 |
| Multi-source development of an integrated model for family health history | 31.7 | 0 | 2 |
| The transformation of morals in markets: death, benefits, and the exchange of life insurance policies | 31.7 | 0 | 2 |
| Population-based incidence of diabetes in Australian youth aged 10-18 yr: increase in type 1 diabetes but not type 2 diabetes. | 31.7 | 0 | 2 |
| Risk factor calculator for medical underwriting of life insurers based on the PROCAM study | 31.7 | 0 | 2 |
| Characteristics of autoimmunity in type 1 diabetes and type 1.5 overlap with type 2 diabetes | 31.7 | 0 | 2 |
| Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes | 31.7 | 0 | 2 |
| Macular Pigment Optical Density is Lower in Type 2 Diabetes, Compared with Type 1 Diabetes and Normal Controls | 31.7 | 0 | 2 |
| Legislation can help children to receive the support they need to manage chronic health conditions like type 1 diabetes at school | 31.7 | 0 | 2 |
| Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus | 31.7 | 0 | 2 |
| Reduction of HbA1c and diabetes-related distress after intervention in a diabetes day care clinic in people with type 2 diabetes but not with type 1 diabetes | 31.7 | 0 | 2 |
| Racial differences in family health history knowledge of type 2 diabetes: exploring the role of interpersonal mechanisms | 31.7 | 0 | 2 |
| Achievement of Adequate Glycemic Control in Patients With Type 2 Diabetes and Comorbid Mental Health Conditions Treated in a Primary Care Setting | 31.7 | 0 | 2 |
| Drug-eluting stents: life insurance with a better death benefit | 31.7 | 0 | 2 |
| Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of M | 31.7 | 0 | 2 |
| Is Cognitive Behavioural Therapy focusing on Depression and Anxiety Effective for People with Long-Term Physical Health Conditions? A Controlled Trial in the Context of Type 2 Diabetes Mellitus | 31.7 | 0 | 2 |
| NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epide | 31.7 | 0 | 2 |
| Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes | 31.7 | 0 | 2 |
| Adaptation and validation of the SMP-T2D questionnaire in Spanish for evaluating self-management of high blood pressure and type 2 diabetes: PAG-DT2+HTA | 31.7 | 0 | 2 |
| A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996. | 31.7 | 0 | 2 |
| The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population | 31.7 | 0 | 2 |
| Management of Type 1 diabetes should be different from Type 2 diabetes at hospital admission. | 31.7 | 0 | 2 |
| Adolescents and young adults with newly diagnosed Type 2 diabetes demonstrate greater carotid intima‐media thickness than those with Type 1 diabetes | 31.7 | 0 | 2 |
| Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11. | 31.7 | 0 | 2 |
| Accumulation of severe hypoglycemia at weekends and in warm seasons in patients with type 1 diabetes but not with type 2 diabetes. | 31.7 | 0 | 2 |
| The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module | 31.7 | 0 | 2 |
| "Type 1 on type 2" diabetes mellitus: autoimmune type 1 diabetes superimposed on established type 2 diabetes | 31.7 | 0 | 2 |
| Utilizing Genomics through Family Health History with the Theory of Planned Behavior: Prediction of Type 2 Diabetes Risk Factors and Preventive Behavior in an African American Population in Florida. | 31.7 | 0 | 2 |
| Evidence for Good Cardiovascular Outcomes among Patients with Type 2 Diabetes, and Promising Treatment for Patients with Type 1 Diabetes | 31.7 | 0 | 2 |
| HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children. | 31.7 | 0 | 2 |
| Life Insurance Policy Holders' Protection Levies Act 1991 | 31.7 | 0 | 2 |
| Life Insurance Policy Holders' Protection Levies Collection Act 1991 | 31.7 | 0 | 2 |
| Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group | 31.7 | 0 | 2 |
| A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy | 31.7 | 0 | 2 |
| Review of Mark A. Rothstein (ed.), Genetics and Life Insurance, Medical Underwriting and Social Policy. Cambridge, MA: The MIT Press, 2004. 293 pp. $34.00, hardcover | 31.7 | 0 | 2 |
| Maternal Gestational Diabetes Mellitus, Type 1 Diabetes, and Type 2 Diabetes During Pregnancy and Risk of ADHD in Offspring | 31.7 | 0 | 2 |
| Cognitive Function Is Impaired in Patients with Recently Diagnosed Type 2 Diabetes, but Not Type 1 Diabetes | 31.7 | 0 | 2 |
| Higher Rate of Obesity and Hypertension in Adolescents With Type 2 Diabetes Than in Those With Type 1 Diabetes | 31.7 | 0 | 2 |
| Empirical Investigation of Life Settlements: The Secondary Market for Life Insurance Policies | 31.7 | 0 | 2 |
| Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: Action LADA 5 | 31.7 | 0 | 2 |
| Comparative Effectiveness of Financial Incentives and Nudges to Reduce Cellphone Use While Driving Among UBI Auto Policy Holders | 31.7 | 0 | 2 |
| Taking Action Together- A Diabetes Prevention Program | 31.7 | 0 | 2 |
| Oklahoma Insurance Quotes | 31.7 | 0 | 2 |
| Validation and cross-cultural adaptation of the depression Patient's Health Questionnaire - 9 in the Romanian population of patients with Type 2 Diabetes Mellitus. | 31.7 | 0 | 2 |
| FGF-21 and Exercise in Relation to Insulin Secretion | 31.7 | 0 | 2 |
| Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes | 31.7 | 0 | 2 |
| Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001) | 31.7 | 0 | 2 |
| KDA sponsored term life insurance | 31.7 | 0 | 2 |
| When to drop that life insurance policy | 31.7 | 0 | 2 |
| Can renal transplant patients take out a life insurance policy? | 31.7 | 0 | 2 |
| A life insurance policy loan--the way to borrow | 31.7 | 0 | 2 |
| How good is that 'forgotten' life insurance policy? 5 | 31.7 | 0 | 2 |
| Retired lives reserve. Maximize the tax benefits under your corporation's group term life insurance plan | 31.7 | 0 | 2 |
| The right life insurance policy for you to drop | 31.7 | 0 | 2 |
| AIDS activists issue safeguards for people with AIDS who sell their life insurance policies | 31.7 | 0 | 2 |
| Life insurance: whole life vs. term--how the federal government analyzes it | 31.7 | 0 | 2 |
| Cornell Medical Index | 31.7 | 0 | 2 |
| Conference on hypertension. Council for High Blood Pressure Research American Heart Association, Inc. Association of Life Insurance Medical Directors of America | 31.7 | 0 | 2 |
| Choosing a life insurance policy | 31.7 | 0 | 2 |
| Type 1 diabetes in the offspring does not increase the risk of parental type 2 diabetes in South Indians | 31.7 | 0 | 2 |
| Summaries for patients. The blood pressure drug losartan appears to benefit the kidneys of people with type 2 diabetes who do not have high blood pressure | 31.7 | 0 | 2 |
| Life insurance policies and the terminally ill | 31.7 | 0 | 2 |
| Experts question validity of PSA testing for life insurance policies | 31.7 | 0 | 2 |
| life insurance company | 31.7 | 0 | 2 |
| DEATH CASES AMONG PERSONS WITH GROUP LIFE INSURANCE POLICIES IN COMMUNITY HOMES | 31.7 | 0 | 2 |
| Irbesartan prevents the progression of kidney disease or death in patients with type 2 diabetes and high blood pressure | 31.7 | 0 | 2 |
| AIDS patients can sell their life insurance policies as final cash reserve | 31.7 | 0 | 2 |
| A comparison of permanent and term life insurance | 31.7 | 0 | 2 |
| HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes | 31.7 | 0 | 2 |
| Genetic screening of patients with familial hypercholesterolemia and insurability for life insurance policies and disability cover policies | 31.7 | 0 | 2 |
| Type 1 diabetes of the child and the adult. Type 2 diabetes of the adult. Complications of diabetes | 31.7 | 0 | 2 |
| Prevalence of hypertension in type 2 diabetes mellitus: impact of the tightening definition of high blood pressure and association with confounding risk factors | 31.7 | 0 | 2 |
| New group term life insurance offered | 31.7 | 0 | 2 |
| Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes | 31.7 | 0 | 2 |
| High-sensitivity C-reactive protein in subjects with type 2 diabetes mellitus and/or high blood pressure | 31.7 | 0 | 2 |
| Premixed biphasic insulin analogs - a choice for pediatric patients with type 2 diabetes rather than type 1 diabetes? | 31.7 | 0 | 2 |
| Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes—A meta-analysis | 31.7 | 0 | 2 |
| High-density lipoprotein subspecies between patients with type 1 diabetes and type 2 diabetes without / with intensive insulin therapy | 31.7 | 0 | 2 |
| Glycemic control and pregnancy outcomes in women with type 2 diabetes from Poland. The impact of pregnancy planning and a comparison with type 1 diabetes subjects | 31.7 | 0 | 2 |
| Glycated albumin levels are higher relative to HbA1c levels in people with autoimmune acute-onset type 1 diabetes mellitus than in people with type 2 diabetes mellitus at the time of diagnosis | 31.7 | 0 | 2 |
| A comparison of physical activity-related social-cognitive factors between those with type 1 diabetes, type 2 diabetes and diabetes free adults | 31.7 | 0 | 2 |
| Life insurance policy loans: tax and other implications | 31.7 | 0 | 2 |
| An Address on HIGH BLOOD PRESSURE, ALBUMINURIA, AND GLYCOSURIA IN THEIR RELATION TO LIFE INSURANCE | 31.7 | 0 | 2 |
| Are you making the most of your life insurance policy? | 31.7 | 0 | 2 |
| The medical history update: compromised or complete? Obtaining--and maintaining--patient health history information | 31.7 | 0 | 2 |
| Collection of family health history for assessment of chronic disease risk in primary care | 31.7 | 0 | 2 |
| Daytime flexible application of Insulin degludec in patients with type 1 diabetes or type 2 diabetes | 31.7 | 0 | 2 |
| Recommendations for healthier hydration: addressing the public health issues of obesity and type 2 diabetes | 31.7 | 0 | 2 |
| 10 years later: Assessing the impact of public health efforts on the collection of family health history | 31.7 | 0 | 2 |
| [Difficult diagnosis in a 17-year-old patient: Type 1 diabetes? Type 2 diabetes? Or "double diabetes"?] | 31.7 | 0 | 2 |
| Type 2 diabetes, high blood pressure and acute pancreatitis | 31.7 | 0 | 2 |
| The clinical characteristics of patients with mitochondrial tRNA Leu(UUR)m.3243A > G mutation: Compared with type 1 diabetes and early onset type 2 diabetes | 31.7 | 0 | 2 |
| Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on "Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study" by Tseng et al., Joint Bo | 31.7 | 0 | 2 |
| Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar | 31.7 | 0 | 2 |
| Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function | 31.7 | 0 | 2 |
| [Bone fragility in type 1 diabetes and type 2 diabetes.] | 31.7 | 0 | 2 |
| Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in Japan | 31.7 | 0 | 2 |
| Distinct neutrophil counts and functions in newly diagnosed type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes | 31.7 | 0 | 2 |
| Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study | 31.7 | 0 | 2 |
| Acute Pancreatitis in Patients With a Medical History of Type 2 Diabetes Mellitus: Clinical Findings and Magnetic Resonance Imaging Characteristics | 31.7 | 0 | 2 |
| Beyond type 2 diabetes: sodium glucose co-transporter-inhibition in type 1 diabetes | 31.7 | 0 | 2 |
| A Case of Fulminant Type 1 Diabetes in a Patient with Type 2 Diabetes Mellitus | 31.7 | 0 | 2 |
| Association between high blood pressure with risk of type 2 diabetes, metabolic syndrome and its predictors: A cross-sectional study | 31.7 | 0 | 2 |
| Young adult patients with type 1 diabetes have a higher risk of mortality than those of similar age with type 2 diabetes: A nationwide analysis in Hungary | 31.7 | 0 | 2 |
| The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes | 31.7 | 0 | 2 |
| Analysis of dietary patterns and cross-sectional and longitudinal associations with hypertension, high BMI and type 2 diabetes in Peru | 31.7 | 0 | 2 |
| Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome | 31.7 | 0 | 2 |
| Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II | 31.7 | 0 | 2 |
| Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes | 31.7 | 0 | 2 |
| THE CHOICE OF A LIFE INSURANCE POLICY | 31.7 | 0 | 2 |
| Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation | 31.7 | 0 | 2 |
| Prevalence and predictors of prediabetes and its coexistence with high blood pressure in first-degree relatives of patients with type 2 diabetes: A 9-year cohort study | 31.7 | 0 | 2 |
| Newer Drugs for Type 2 Diabetes: An Emerging Adjunctive Therapy to Insulin for Type 1 Diabetes? | 31.7 | 0 | 2 |
| Survey regarding mental health conditions of high school students and attitudes of students and their teachers toward students' mental health issues | 31.7 | 0 | 2 |
| Health History Vital in Assessing Patients, Reducing Risk | 31.7 | 0 | 2 |
| [Daytime flexible application of Insulin degludec in patients with type 1 diabetes or type 2 diabetes] | 31.7 | 0 | 2 |
| Leader Legacy Building: An Organization's Life Insurance Policy | 31.7 | 0 | 2 |
| Live-born children after assisted reproduction in women with type 1 diabetes and type 2 diabetes: a nationwide cohort study | 31.7 | 0 | 2 |
| Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment | 31.7 | 0 | 2 |
| Bone mineral density spectrum in individuals with type 1 diabetes, LADA, and type 2 diabetes | 31.7 | 0 | 2 |
| Individuals with Peripheral Artery Disease (PAD) and Type 1 Diabetes Are More Likely to Undergo Limb Amputation than Those with PAD and Type 2 Diabetes | 31.7 | 0 | 2 |
| Type 1 diabetes, obesity and PCOS: Is type 1 stepping into the shoes of type 2 diabetes? | 31.7 | 0 | 2 |
| Higher BMI is associated with smaller regional brain volume in older adults with type 2 diabetes | 31.7 | 0 | 2 |
| Evolving type 1 diabetes in distinguishing between type 1 and type 2 diabetes | 31.7 | 0 | 2 |
| Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism | 31.7 | 0 | 2 |
| Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: a cross sectional study | 31.7 | 0 | 2 |
| Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study | 31.7 | 0 | 2 |
| Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Results from the German Cohort of a Global Survey of People with Type 1 Diabetes or Insulin-Treated Type 2 Diabetes and Caregivers | 31.7 | 0 | 2 |
| Increased spontaneous CCL2 (MCP-1) and CCL5 (RANTES) secretion in vitro in LADA compared to type 1 diabetes and type 2 diabetes: Action LADA 14 | 31.7 | 0 | 2 |
| Impact of Obesity on Measures of Cardiovascular and Kidney Health in Youth With Type 1 Diabetes as Compared With Youth With Type 2 Diabetes | 31.7 | 0 | 2 |
| Des Moines Savings Bank v. Krell | 31.7 | 0 | 2 |
| Price Elasticity of Demand for Term Life Insurance and Adverse Selection | 31.7 | 0 | 2 |
| Life Insurance (Ireland) Act 1866 | 31.7 | 0 | 2 |
| Profile Screening of Differentially Expressed lncRNAs of Circulating Leukocytes in Type 2 Diabetes Patients and Differences From Type 1 Diabetes | 31.7 | 0 | 2 |
| Insurance: Insurable Interest: Assignment of Life Insurance Policy as Collateral Security | 31.7 | 0 | 2 |
| Assignment of Life Insurance Policies as Collateral Security | 31.7 | 0 | 2 |
| Participating life insurance policies: an accurate and efficient parallel software for COTS clusters | 31.7 | 0 | 2 |
| HCPO Website | 31.7 | 0 | 2 |
| A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes | 31.7 | 0 | 2 |
| The Different Response of Endocrine Hormones to Hypoglycemia in Patients With Type 1 or Type 2 Diabetes | 31.7 | 0 | 2 |
| Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D | 31.7 | 0 | 2 |
| Renal Threshold for Glucose Re-Absorption in Patients with Latent Autoimmune Diabetes of Adults is Similar to That of Patients with Type 1 Diabetes Mellitus but Lower than That of Patients with Type 2 Diabetes Mellitus | 31.7 | 0 | 2 |
| THE PHYSICAL IMPAIRMENTS OF ADULT LIFE. PREVALENCE AT DIFFERENT AGES, BASED ON MEDICAL EXAMINATIONS BY THE LIFE EXTENSION INSTITUTE OF 100,924 WHITE MALE LIFE INSURANCE POLICY HOLDERS SINCE 1921* | 31.7 | 0 | 2 |
| Calculation of the internal rate of return of universal life insurance product and analysis on relevant factors | 31.7 | 0 | 2 |
| The pledge of the life insurance policy | 31.7 | 0 | 2 |
| A Forward-looking Research on the Prevention of Money Laundering Risk in Life Insurance Policy Viatical Settlement | 31.7 | 0 | 2 |
| The pros and cons for life insurance policy securitization | 31.7 | 0 | 2 |
| A study on legal issues relating to mandatory execution of life insurance policies | 31.7 | 0 | 2 |
| An Macro and Micro Analysis of Determinants for Life Insurance Policy Surrender Rate | 31.7 | 0 | 2 |
| An Investigation on the Market Selection of Universal Life Insurance | 31.7 | 0 | 2 |
| The Optimal Guaranteed Interest Rate for Sustainable Development of China’s Universal Life Insurance | 31.7 | 0 | 2 |
| A Study on Factors Affecting Life Insurance Policy Surrender——Based on the Interpretation of Information Cognitive Bias | 31.7 | 0 | 2 |
| The Change of Readability of Life Insurance Policy in China and Model Clause Effect | 31.7 | 0 | 2 |
| Valuation of Life Insurance Policies with Embedded Surrender Option | 31.7 | 0 | 2 |
| Characteristics of Healthcare Allocation Within Family in China: Analysis Based on Short-term Health Insurance Policies from China’s Life Insurance Companies | 31.7 | 0 | 2 |
| Ruin Model of Term Life Insurance | 31.7 | 0 | 2 |
| A Note to Ruin Model of Term Life Insurance | 31.7 | 0 | 2 |
| Fuzzy Similarity Analysis and Clustering Study on the Structure of Life Insurance Policies | 31.7 | 0 | 2 |
| Foreign Divorce as Automatic Transfer of Life Insurance Policy | 31.7 | 0 | 2 |
| A STUDY ON REDEFINING TRADITIONAL WAYS OF MARKETING OF LIFE INSURANCE POLICY IN CURRENT DIGITAL ERA | 31.7 | 0 | 2 |
| Circulating Tissue Factor Procoagulant Activity (TF-PCA) Is Elevated in Type 1 Diabetes Mellitus: Differential Regulation of TF-PCA in Type 1 and Type 2 Diabetes | 31.7 | 0 | 2 |
| The Insurance of Mass Murder: The Development of Slave Life Insurance Policies of Dutch Private Slave Ships, 1720–1780 | 31.7 | 0 | 2 |
| Benchmarked Risk Minimizing Hedging Strategies for Life Insurance Policies | 31.7 | 0 | 2 |
| Factor Influncing the Demand of Life Insurance Policy | 31.7 | 0 | 2 |
| Factors Influencing the Choice of Investment in Life Insurance Policy | 31.7 | 0 | 2 |
| Influence of Corporate’s Image and Service to Loyalty of Life Insurance Policy Holders in Indonesia | 31.7 | 0 | 2 |
| Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy | 31.7 | 0 | 2 |
| Higher BMI in Childhood: The Contributory Factor For Type 2 Diabetes and Cardiovascular Disease in Adulthood | 31.7 | 0 | 2 |
| Anatomy of a Life Insurance Policy | 31.7 | 0 | 2 |
| Profit Testing of Profit Sharing Life Insurance Policies in the Presence of Extreme Risks | 31.7 | 0 | 2 |
| Evaluation of participating endowment life insurance policies in a stochastic environment | 31.7 | 0 | 2 |
| Factors Affecting Purchase Decision of Life Insurance Policy of Customer in Chitwan | 31.7 | 0 | 2 |
| A Type 1 Diabetes Polygenic Score Is Not Associated With Prevalent Type 2 Diabetes in Large Population Studies | 31.7 | 0 | 2 |
| Information System for Notification of Health Issues | 31.7 | 0 | 2 |
| Q135239939 | 31.7 | 0 | 2 |
| Q135290757 | 31.7 | 0 | 2 |
| Q135290797 | 31.7 | 0 | 2 |
| Universal Life Insurance Building | 31.7 | 0 | 2 |
| The demise of the mutual life insurer: An analysis of the impact of regulatory change on the performance of Australian life insurers in the 1990s | 31.7 | 0 | 2 |
| Peter Rosengard | 31.7 | 0 | 2 |
| United States Congress | 25.8 | 1 | 0 |
| Aflac | 25.8 | 1 | 0 |
| American International Group | 25.8 | 1 | 0 |
| Lincoln Motor Company | 25.8 | 1 | 0 |
| A. M. Best | 25.8 | 1 | 0 |
| AARP | 25.8 | 1 | 0 |
| The World's Billionaires | 25.8 | 1 | 0 |
| Lincoln Town Car | 25.8 | 1 | 0 |
| Gerber Products Company | 25.8 | 1 | 0 |
| Money | 25.8 | 1 | 0 |
| Forbes | 25.8 | 1 | 0 |
| The World's Most Powerful People | 25.8 | 1 | 0 |
| Forbes Global 2000 | 25.8 | 1 | 0 |
| Lincoln MKT | 25.8 | 1 | 0 |
| Pacific Life | 25.8 | 1 | 0 |
| Symetra | 25.8 | 1 | 0 |
| Mike Lazaridis | 25.8 | 1 | 0 |
| Lincoln Navigator | 25.8 | 1 | 0 |
| Reinsurance Group of America | 25.8 | 1 | 0 |
| Forbes 400 | 25.8 | 1 | 0 |
| E-Trade | 25.8 | 1 | 0 |
| AARP the Magazine | 25.8 | 1 | 0 |
| Bankrate | 25.8 | 1 | 0 |
| Congressional Record | 25.8 | 1 | 0 |
| Consumer Federation of America | 25.8 | 1 | 0 |
| eHealthInsurance | 25.8 | 1 | 0 |
| National General Insurance | 25.8 | 1 | 0 |
| Haven Holidays | 25.8 | 1 | 0 |
| Independent Order of Foresters | 25.8 | 1 | 0 |
| John Hancock Insurance | 25.8 | 1 | 0 |
| LendingTree | 25.8 | 1 | 0 |
| Nationwide Mutual Insurance Company | 25.8 | 1 | 0 |
| NetQuote | 25.8 | 1 | 0 |
| Nolo.com | 25.8 | 1 | 0 |
| Progressive Corporation | 25.8 | 1 | 0 |
| Protective Life | 25.8 | 1 | 0 |
| Trumpia | 25.8 | 1 | 0 |
| Trupanion | 25.8 | 1 | 0 |
| USAA | 25.8 | 1 | 0 |
| Forbes' list of the world's highest-paid athletes | 25.8 | 1 | 0 |
| healthcare.gov | 25.8 | 1 | 0 |
| Craig Tara | 25.8 | 1 | 0 |
| Lincoln MKC | 25.8 | 1 | 0 |
| Vance McAllister | 25.8 | 1 | 0 |
| BTCC | 25.8 | 1 | 0 |
| Stephen Brobeck | 25.8 | 1 | 0 |
| Mohamed Mansour | 25.8 | 1 | 0 |
| Bright House Networks | 25.8 | 1 | 0 |
| Independent Insurance Agents & Brokers of America | 25.8 | 1 | 0 |
| Securian Financial Group | 25.8 | 1 | 0 |
| Hagerty Insurance Agency | 25.8 | 1 | 0 |
| Mutual of Omaha | 25.8 | 1 | 0 |
| amnesia | 20.0 | 0 | 1 |
| arterial hypertension | 20.0 | 0 | 1 |
| type-1 diabetes | 20.0 | 0 | 1 |
| sudden infant death syndrome | 20.0 | 0 | 1 |
| Meiji Yasuda Life | 20.0 | 0 | 1 |
| medical history | 20.0 | 0 | 1 |
| Lina Medina | 20.0 | 0 | 1 |
| diseases of affluence | 20.0 | 0 | 1 |
| death benefit | 20.0 | 0 | 1 |
| perindopril | 20.0 | 0 | 1 |
| whole-life cost | 20.0 | 0 | 1 |
| insurance broker | 20.0 | 0 | 1 |
| Aegon | 20.0 | 0 | 1 |
| immunoglobulin therapy | 20.0 | 0 | 1 |
| FTLife | 20.0 | 0 | 1 |
| atenolol | 20.0 | 0 | 1 |
| amlodipine | 20.0 | 0 | 1 |
| olmesartan | 20.0 | 0 | 1 |
| enalapril | 20.0 | 0 | 1 |
| nadolol | 20.0 | 0 | 1 |
| David Helfgott | 20.0 | 0 | 1 |
| Incheon Heungkuk Life Pink Spiders | 20.0 | 0 | 1 |
| Hanwha Life Insurance | 20.0 | 0 | 1 |
| embedded value | 20.0 | 0 | 1 |
| Your Whole Life Ahead of You | 20.0 | 0 | 1 |
| neurasthenia | 20.0 | 0 | 1 |
| Nippon Life Insurance Company | 20.0 | 0 | 1 |
| German Museum of Medical History | 20.0 | 0 | 1 |
| SuperFreakonomics | 20.0 | 0 | 1 |
| The Dai-ichi Life Insurance Company | 20.0 | 0 | 1 |
| Samsung Life Insurance | 20.0 | 0 | 1 |
| life insurance | 20.0 | 0 | 1 |
| occupational disease | 20.0 | 0 | 1 |
| Metropolitan Life Insurance Company Tower | 20.0 | 0 | 1 |
| metabolic syndrome | 20.0 | 0 | 1 |
| Aryanization | 20.0 | 0 | 1 |
| Q689238 | 20.0 | 0 | 1 |
| Genesis P-Orridge | 20.0 | 0 | 1 |
| Atlantic Mutual Insurance Company | 20.0 | 0 | 1 |
| KB Life Insurance | 20.0 | 0 | 1 |
| Heungkuk Life | 20.0 | 0 | 1 |
| eprosartan | 20.0 | 0 | 1 |
| Berlin Museum of Medical History at the Charité | 20.0 | 0 | 1 |
| Mental health court | 20.0 | 0 | 1 |
| diabetic ketoacidosis | 20.0 | 0 | 1 |
| Universal Life | 20.0 | 0 | 1 |
| sanitation | 20.0 | 0 | 1 |
| insurance policy | 20.0 | 0 | 1 |
| Chinese Museum of Medical History | 20.0 | 0 | 1 |
| China Pacific Insurance | 20.0 | 0 | 1 |
| Heart Condition | 20.0 | 0 | 1 |
| Walking | 20.0 | 0 | 1 |
| China Life Insurance Company | 20.0 | 0 | 1 |
| unit-linked insurance plan | 20.0 | 0 | 1 |
| Sumitomo Life Insurance Company | 20.0 | 0 | 1 |
| The Pyramids | 20.0 | 0 | 1 |
| personal flotation device | 20.0 | 0 | 1 |
| medical record | 20.0 | 0 | 1 |
| Prudential plc | 20.0 | 0 | 1 |
| Fairfax Financial | 20.0 | 0 | 1 |
| Manhattan Life Insurance Building | 20.0 | 0 | 1 |
| Payment protection insurance | 20.0 | 0 | 1 |
| Semmelweis Museum of Medical History | 20.0 | 0 | 1 |
| nephrosclerosis | 20.0 | 0 | 1 |
| Josephinum | 20.0 | 0 | 1 |
| New York Life Building | 20.0 | 0 | 1 |
| genogram | 20.0 | 0 | 1 |
| Yamato Life | 20.0 | 0 | 1 |
| PHQ-4 | 20.0 | 0 | 1 |
| PHQ-15 | 20.0 | 0 | 1 |
| Manulife Financial | 20.0 | 0 | 1 |
| Kansas City Life Insurance Company | 20.0 | 0 | 1 |
| Patient Health Questionnaire | 20.0 | 0 | 1 |
| medical anthropology | 20.0 | 0 | 1 |
| LV 1871 | 20.0 | 0 | 1 |
| Liddle syndrome | 20.0 | 0 | 1 |
| Maxell | 20.0 | 0 | 1 |
| PHQ-2 | 20.0 | 0 | 1 |
| PHQ-9 | 20.0 | 0 | 1 |
| life settlement | 20.0 | 0 | 1 |
| auriculotherapy | 20.0 | 0 | 1 |
| Curiosity Killed the Cat | 20.0 | 0 | 1 |
| dissociative disorder | 20.0 | 0 | 1 |
| glucose intolerance | 20.0 | 0 | 1 |
| general insurance | 20.0 | 0 | 1 |
| Life Insurance Corporation of India | 20.0 | 0 | 1 |
| My Whole Life Is Thunder | 20.0 | 0 | 1 |
| Executive Life Insurance Company | 20.0 | 0 | 1 |
| family medical history | 20.0 | 0 | 1 |
| Death benefit in Morocco | 20.0 | 0 | 1 |
| life imprisonment in England and Wales | 20.0 | 0 | 1 |
| Meiji Seimei Kan | 20.0 | 0 | 1 |
| type 2 diabetes | 20.0 | 0 | 1 |
| La Suisse Assurances | 20.0 | 0 | 1 |
| Meiji Yasuda Life Insurance Building | 20.0 | 0 | 1 |
| Nissay Marunouchi Building | 20.0 | 0 | 1 |
| Scottish Widows | 20.0 | 0 | 1 |
| resuscitation unit | 20.0 | 0 | 1 |
| endowment policy | 20.0 | 0 | 1 |
| psychological stress | 20.0 | 0 | 1 |
| immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome | 20.0 | 0 | 1 |
| Taiyo Life Shinagawa Building | 20.0 | 0 | 1 |
| In Prison My Whole Life | 20.0 | 0 | 1 |
| insurance type | 20.0 | 0 | 1 |
| New York Life Insurance Building | 20.0 | 0 | 1 |
| tachyarrhythmia | 20.0 | 0 | 1 |
| diabesity | 20.0 | 0 | 1 |
| casualty insurance | 20.0 | 0 | 1 |
| Azimzhan Askarov | 20.0 | 0 | 1 |
| National Western Life | 20.0 | 0 | 1 |
| cancellation | 20.0 | 0 | 1 |
| hypertensive encephalopathy | 20.0 | 0 | 1 |
| Nine Days and the Whole Life | 20.0 | 0 | 1 |
| mortgage insurance | 20.0 | 0 | 1 |
| mental health care | 20.0 | 0 | 1 |
| Thomas Lord Cromwell | 20.0 | 0 | 1 |
| Universal Life Church | 20.0 | 0 | 1 |
| Mauriac syndrome | 20.0 | 0 | 1 |
| Acacia Life Insurance Company | 20.0 | 0 | 1 |
| addiction psychiatry | 20.0 | 0 | 1 |
| additional insured | 20.0 | 0 | 1 |
| Afro-American Life Insurance Company | 20.0 | 0 | 1 |
| Allianz Life | 20.0 | 0 | 1 |
| American Council of Life Insurers | 20.0 | 0 | 1 |
| Ameritas Life Insurance Company | 20.0 | 0 | 1 |
| Amicable Society for a Perpetual Assurance Office | 20.0 | 0 | 1 |
| Annual premium equivalent | 20.0 | 0 | 1 |
| Asahi Life | 20.0 | 0 | 1 |
| Atlanta Life | 20.0 | 0 | 1 |
| Attending physician statement | 20.0 | 0 | 1 |
| Bajaj Life Insurance | 20.0 | 0 | 1 |
| Berkshire Life Insurance Company Building | 20.0 | 0 | 1 |
| Bermuda Form | 20.0 | 0 | 1 |
| Business overhead expense disability insurance | 20.0 | 0 | 1 |
| CUNA Mutual Group | 20.0 | 0 | 1 |
| diagnostic test in cardiology | 20.0 | 0 | 1 |
| Catholic Knights of America | 20.0 | 0 | 1 |
| Chicago Life Insurance Company v. Needles | 20.0 | 0 | 1 |
| Child Life Insurance | 20.0 | 0 | 1 |
| KGI Life Insurance Company | 20.0 | 0 | 1 |
| health of Frédéric Chopin | 20.0 | 0 | 1 |
| Chronic care management | 20.0 | 0 | 1 |
| Civil Auto Liability | 20.0 | 0 | 1 |
| disease cluster | 20.0 | 0 | 1 |
| Connecticut General Life Insurance Company Headquarters | 20.0 | 0 | 1 |
| Connecticut General Life Insurance Company v. Johnson | 20.0 | 0 | 1 |
| sharing of costs | 20.0 | 0 | 1 |
| DESMOND | 20.0 | 0 | 1 |
| David Cushman | 20.0 | 0 | 1 |
| Death bond | 20.0 | 0 | 1 |
| insurance market death spiral | 20.0 | 0 | 1 |
| Delta Life Insurance Company Limited Building | 20.0 | 0 | 1 |
| diabulimia | 20.0 | 0 | 1 |
| Dittrick Museum of Medical History | 20.0 | 0 | 1 |
| Edmonton protocol | 20.0 | 0 | 1 |
| Liz Cheney | 20.0 | 0 | 1 |
| Elm Street Historic District | 20.0 | 0 | 1 |
| Equitable Building | 20.0 | 0 | 1 |
| Expatriate insurance | 20.0 | 0 | 1 |
| First Colony Life Insurance Company | 20.0 | 0 | 1 |
| First United American Life Insurance Company | 20.0 | 0 | 1 |
| Former New York Life Insurance Company Building | 20.0 | 0 | 1 |
| Frank Gross | 20.0 | 0 | 1 |
| Garry McDonald | 20.0 | 0 | 1 |
| Genetic causes of diabetes mellitus type 2 | 20.0 | 0 | 1 |
| Gerhard Gesell | 20.0 | 0 | 1 |
| W New York Union Square | 20.0 | 0 | 1 |
| GET LAMP: The Text Adventure Documentary | 20.0 | 0 | 1 |
| glucagon-like peptide-1 agonist | 20.0 | 0 | 1 |
| Golden State Mutual Life Insurance Building | 20.0 | 0 | 1 |
| Golden State Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Gross Revenue Insurance Plan | 20.0 | 0 | 1 |
| Guaranteed issue | 20.0 | 0 | 1 |
| HDFC Life | 20.0 | 0 | 1 |
| Hand in Hand Fire & Life Insurance Society | 20.0 | 0 | 1 |
| Hanil Life Insurance FC | 20.0 | 0 | 1 |
| health assessment | 20.0 | 0 | 1 |
| health issues in American football | 20.0 | 0 | 1 |
| Health issues in youth athletics | 20.0 | 0 | 1 |
| Health issues in athletics | 20.0 | 0 | 1 |
| Heart condition | 20.0 | 0 | 1 |
| Historian | 20.0 | 0 | 1 |
| Hypertensive urgency | 20.0 | 0 | 1 |
| Hypokinetic diseases | 20.0 | 0 | 1 |
| IndiaFirst Life Insurance Company | 20.0 | 0 | 1 |
| Indiana Medical History Museum | 20.0 | 0 | 1 |
| Agricultural Insurance Pool | 20.0 | 0 | 1 |
| Breakthrough T1D | 20.0 | 0 | 1 |
| Jackie Duffin | 20.0 | 0 | 1 |
| Japan Post Insurance | 20.0 | 0 | 1 |
| John Funder | 20.0 | 0 | 1 |
| Juvenile Life Insurance | 20.0 | 0 | 1 |
| Wright Tower | 20.0 | 0 | 1 |
| Category:MetLife | 20.0 | 0 | 1 |
| Category:Life insurance companies | 20.0 | 0 | 1 |
| Category:Life insurance companies of Switzerland | 20.0 | 0 | 1 |
| Kentucky Central Insurance Company | 20.0 | 0 | 1 |
| key person insurance | 20.0 | 0 | 1 |
| Kirby J. Hensley | 20.0 | 0 | 1 |
| Kyobo Life | 20.0 | 0 | 1 |
| HANA NON LIFE INSURANCE | 20.0 | 0 | 1 |
| LLQP | 20.0 | 0 | 1 |
| Left axis deviation | 20.0 | 0 | 1 |
| Liberty National Life Insurance Company | 20.0 | 0 | 1 |
| Life Insurance | 20.0 | 0 | 1 |
| Life insurance tax shelter | 20.0 | 0 | 1 |
| life insurance trust | 20.0 | 0 | 1 |
| Lifestyle causes of diabetes mellitus type 2 | 20.0 | 0 | 1 |
| Lincoln Income Life Insurance Company | 20.0 | 0 | 1 |
| lipoatrophic diabetes | 20.0 | 0 | 1 |
| list of ministers of the Universal Life Church | 20.0 | 0 | 1 |
| list of people with type 1 diabetes mellitus | 20.0 | 0 | 1 |
| list of prisoners with whole-life tariffs | 20.0 | 0 | 1 |
| London Life Insurance Company | 20.0 | 0 | 1 |
| Template:CMS Medical history types | 20.0 | 0 | 1 |
| Margin on Services | 20.0 | 0 | 1 |
| Max Life Insurance | 20.0 | 0 | 1 |
| McGee v. International Life Insurance Co. | 20.0 | 0 | 1 |
| Medical History | 20.0 | 0 | 1 |
| Medical Mutual of Ohio | 20.0 | 0 | 1 |
| Medical underwriting | 20.0 | 0 | 1 |
| Met English | 20.0 | 0 | 1 |
| Michael Rutter Centre for Children and Adolescents | 20.0 | 0 | 1 |
| Mid-term adjustment | 20.0 | 0 | 1 |
| Miners' health issues during 2010 Copiapó mining accident | 20.0 | 0 | 1 |
| Mobile Life Insurance Company v. Brame | 20.0 | 0 | 1 |
| Mold health issues | 20.0 | 0 | 1 |
| Mortgage life insurance | 20.0 | 0 | 1 |
| Mosaic Dallas | 20.0 | 0 | 1 |
| Muang Thai Life Assurance | 20.0 | 0 | 1 |
| Mutual Benefit Life Insurance Company | 20.0 | 0 | 1 |
| Mutual Life Insurance Co. of New York v. Hillmon | 20.0 | 0 | 1 |
| Mutual Life Insurance Co of New York v The Rank Organisation Ltd | 20.0 | 0 | 1 |
| National Guardian Life | 20.0 | 0 | 1 |
| National Income Life Insurance Company | 20.0 | 0 | 1 |
| National Life Group | 20.0 | 0 | 1 |
| National Life Group | 20.0 | 0 | 1 |
| New England Mutual Life Insurance Co. v. Woodworth | 20.0 | 0 | 1 |
| New York Life Insurance Building | 20.0 | 0 | 1 |
| New York Life Ins. Co. v. Dunlevy | 20.0 | 0 | 1 |
| New York Life Insurance Building, Chicago | 20.0 | 0 | 1 |
| Norsk Kollektiv Pensjonskasse | 20.0 | 0 | 1 |
| North Carolina Institute of Medicine | 20.0 | 0 | 1 |
| North Carolina Mutual Life Insurance Company Building | 20.0 | 0 | 1 |
| Northwestern National Life Insurance Co. v. Riggs | 20.0 | 0 | 1 |
| Ohio Life Insurance and Trust Company | 20.0 | 0 | 1 |
| Olivia Colman | 20.0 | 0 | 1 |
| Onderlinge van 1719 u.a. | 20.0 | 0 | 1 |
| Our Whole Lives | 20.0 | 0 | 1 |
| Owner-controlled insurance program | 20.0 | 0 | 1 |
| past medical history | 20.0 | 0 | 1 |
| Pension term assurance | 20.0 | 0 | 1 |
| Perelman Building | 20.0 | 0 | 1 |
| Permanent life insurance | 20.0 | 0 | 1 |
| Phoenix Mutual Life Insurance Building | 20.0 | 0 | 1 |
| Pre-existing Condition Insurance Plan | 20.0 | 0 | 1 |
| pre-existing condition | 20.0 | 0 | 1 |
| prevention of diabetes mellitus type 2 | 20.0 | 0 | 1 |
| primary ventricular fibrillation | 20.0 | 0 | 1 |
| IndusInd Nippon Life Insurance | 20.0 | 0 | 1 |
| renters insurance | 20.0 | 0 | 1 |
| Return of premium life insurance | 20.0 | 0 | 1 |
| Etiqa | 20.0 | 0 | 1 |
| RiverSource | 20.0 | 0 | 1 |
| SBI Life Insurance Company Limited | 20.0 | 0 | 1 |
| Seaneen Molloy | 20.0 | 0 | 1 |
| Servicemembers' Group Life Insurance | 20.0 | 0 | 1 |
| social history | 20.0 | 0 | 1 |
| Sony Life | 20.0 | 0 | 1 |
| Sudden unexpected nocturnal death syndrome | 20.0 | 0 | 1 |
| sustainable product | 20.0 | 0 | 1 |
| Taikang Life | 20.0 | 0 | 1 |
| tertatolol | 20.0 | 0 | 1 |
| The Environmental Determinants of Diabetes in the Young | 20.0 | 0 | 1 |
| The Equitable Life Assurance Society | 20.0 | 0 | 1 |
| Traded Life Policies | 20.0 | 0 | 1 |
| umbrella insurance | 20.0 | 0 | 1 |
| Union Central Life Insurance Company | 20.0 | 0 | 1 |
| Union Labor Life Insurance Company | 20.0 | 0 | 1 |
| United Investors Life Insurance Company | 20.0 | 0 | 1 |
| Universal Life | 20.0 | 0 | 1 |
| Category:Health issues in pregnancy | 20.0 | 0 | 1 |
| Value of in-force | 20.0 | 0 | 1 |
| WoodmenLife | 20.0 | 0 | 1 |
| World Hypertension Day | 20.0 | 0 | 1 |
| Zombie fund | 20.0 | 0 | 1 |
| IDBI Federal Life Insurance | 20.0 | 0 | 1 |
| Category:Life insurance companies of India | 20.0 | 0 | 1 |
| hypertensive heart disease | 20.0 | 0 | 1 |
| clinical interview | 20.0 | 0 | 1 |
| Category:Universal Life Church | 20.0 | 0 | 1 |
| Category:Universal Life Church Wikipedians | 20.0 | 0 | 1 |
| Category:Sumitomo Life | 20.0 | 0 | 1 |
| Category:Fukoku Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Category:Nippon Life | 20.0 | 0 | 1 |
| Category:Meiji Yasuda Life Insurance Company | 20.0 | 0 | 1 |
| Category:Asahi Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Cathay Life Insurance | 20.0 | 0 | 1 |
| Category:Life insurance | 20.0 | 0 | 1 |
| Category:Dai-ichi Life | 20.0 | 0 | 1 |
| Your Whole Life Is Leading Up to This | 20.0 | 0 | 1 |
| electronic health record | 20.0 | 0 | 1 |
| Taiwan Life | 20.0 | 0 | 1 |
| BOC Life | 20.0 | 0 | 1 |
| Japanese Colonial-era Imperial Life Insurance Building | 20.0 | 0 | 1 |
| Shin Kong Life | 20.0 | 0 | 1 |
| New China Life Insurance Co., Ltd. | 20.0 | 0 | 1 |
| FWD Life Insurance | 20.0 | 0 | 1 |
| Sompo Himawari Life Insurance Inc. | 20.0 | 0 | 1 |
| Marunouchi My Plaza | 20.0 | 0 | 1 |
| Korea Life Insurance Association | 20.0 | 0 | 1 |
| Korea Non-Life Insurance Association | 20.0 | 0 | 1 |
| Aioi Life Insurance | 20.0 | 0 | 1 |
| Organization for Postal Savings, Postal Life Insurance and Post Office Network | 20.0 | 0 | 1 |
| Axa Life Insurance | 20.0 | 0 | 1 |
| Gibraltar Life Insurance | 20.0 | 0 | 1 |
| Axa Direct Life Insurance | 20.0 | 0 | 1 |
| SBI Life Insurance | 20.0 | 0 | 1 |
| Mitsui Sumitomo Aioi Life Insurance | 20.0 | 0 | 1 |
| Mitsui Sumitomo Primary Life Insurance | 20.0 | 0 | 1 |
| Taiju Life Insurance | 20.0 | 0 | 1 |
| National Federation of Life Insurance Workers' Unions | 20.0 | 0 | 1 |
| Yachiyo Life Insurance | 20.0 | 0 | 1 |
| Foreign Non-Life Insurance Association of Japan | 20.0 | 0 | 1 |
| Daido Life Insurance Company | 20.0 | 0 | 1 |
| Taiyo Life Insurance | 20.0 | 0 | 1 |
| Fukoku Mutual Life Insurance | 20.0 | 0 | 1 |
| non-life insurance contract | 20.0 | 0 | 1 |
| non-life insurance premium | 20.0 | 0 | 1 |
| Nippon Life Stadium | 20.0 | 0 | 1 |
| Nippon Life Baseball Team | 20.0 | 0 | 1 |
| Nipponkoa Life Insurance | 20.0 | 0 | 1 |
| Hibiya City | 20.0 | 0 | 1 |
| Asahi-seimei Ōtemachi building | 20.0 | 0 | 1 |
| Act on the Management Organization for Postal Savings and Postal Life Insurance, Independent Administrative Agency | 20.0 | 0 | 1 |
| The Life Insurance Association of Japan | 20.0 | 0 | 1 |
| life insurance premium deduction | 20.0 | 0 | 1 |
| Dai-ichi Seimei Hall | 20.0 | 0 | 1 |
| Postal Life Insurance Welfare Corporation | 20.0 | 0 | 1 |
| Nissay Greatwall Life Insurance | 20.0 | 0 | 1 |
| Utmost PanEurope | 20.0 | 0 | 1 |
| Q11880746 | 20.0 | 0 | 1 |
| mental health nurse | 20.0 | 0 | 1 |
| medical record book | 20.0 | 0 | 1 |
| rehabilitation psychology | 20.0 | 0 | 1 |
| Q12470640 | 20.0 | 0 | 1 |
| Q12495904 | 20.0 | 0 | 1 |
| Template:Health issues of plastics | 20.0 | 0 | 1 |
| Children and Families (Wales) Measure 2010 | 20.0 | 0 | 1 |
| Northwestern National Life Insurance Company Home Office | 20.0 | 0 | 1 |
| Mount McGregor | 20.0 | 0 | 1 |
| ING Life India | 20.0 | 0 | 1 |
| New York Mutual Life Insurance Company Building | 20.0 | 0 | 1 |
| Category:Life insurance companies of the United States | 20.0 | 0 | 1 |
| Category:Organizations for children with health issues | 20.0 | 0 | 1 |
| David Aaron Kessler | 20.0 | 0 | 1 |
| AEGON Religare Life Insurance | 20.0 | 0 | 1 |
| Women's Health Issues | 20.0 | 0 | 1 |
| Health Issues | 20.0 | 0 | 1 |
| Medical History | 20.0 | 0 | 1 |
| Canadian Bulletin of Medical History | 20.0 | 0 | 1 |
| Disperse | 20.0 | 0 | 1 |
| BankTaiwan Life Insurance | 20.0 | 0 | 1 |
| First Life Insurance Co., Ltd. | 20.0 | 0 | 1 |
| Fubon Life | 20.0 | 0 | 1 |
| Gleaner Life Insurance Society | 20.0 | 0 | 1 |
| Middle Eastern Mental Health Issues & Syndromes | 20.0 | 0 | 1 |
| Orange Life Insurance | 20.0 | 0 | 1 |
| Federal Employees’ Group Life Insurance Act | 20.0 | 0 | 1 |
| Health Initiative of the Americas | 20.0 | 0 | 1 |
| Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Supreme Life Building | 20.0 | 0 | 1 |
| Ohio National Life Insurance Company | 20.0 | 0 | 1 |
| Fidelity Union Life Insurance Company | 20.0 | 0 | 1 |
| National Black Justice Coalition | 20.0 | 0 | 1 |
| A Pre-existing Condition | 20.0 | 0 | 1 |
| Home State Life Insurance Company | 20.0 | 0 | 1 |
| Insurance Repository | 20.0 | 0 | 1 |
| Genetic causes of diabetes mellitus type 1 | 20.0 | 0 | 1 |
| income protection insurance | 20.0 | 0 | 1 |
| Life insurance in India | 20.0 | 0 | 1 |
| Penn Mutual | 20.0 | 0 | 1 |
| Stranger-originated life insurance | 20.0 | 0 | 1 |
| Manhattan Life Insurance Company | 20.0 | 0 | 1 |
| North Carolina Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Volume overload | 20.0 | 0 | 1 |
| Term Life | 20.0 | 0 | 1 |
| Medical Heritage Library | 20.0 | 0 | 1 |
| legal status of the Universal Life Church | 20.0 | 0 | 1 |
| review of systems | 20.0 | 0 | 1 |
| Aegon Sony Life Insurance | 20.0 | 0 | 1 |
| Category:New York Life Insurance Company | 20.0 | 0 | 1 |
| Sun Life Building | 20.0 | 0 | 1 |
| 27, 28 And 29 St Andrew Square And 1 North St Andrew Lane | 20.0 | 0 | 1 |
| Seeds placed in Norwegian vault as agricultural 'insurance policy' | 20.0 | 0 | 1 |
| Turkmenistan President Niyazov dies of heart condition | 20.0 | 0 | 1 |
| Gene that causes deadly heart condition identified | 20.0 | 0 | 1 |
| Immediate life insurance website launched, first in world | 20.0 | 0 | 1 |
| U.S. study says Type 2 diabetes in youth is hard to control | 20.0 | 0 | 1 |
| Toronto team-led research on Type 1 Diabetes 'groundbreaking' | 20.0 | 0 | 1 |
| G8 reaches deal on African aid for health issues | 20.0 | 0 | 1 |
| Minsheng Life Insurance | 20.0 | 0 | 1 |
| Museum of Medical History, Gothenburg | 20.0 | 0 | 1 |
| T2dm3 | 20.0 | 0 | 1 |
| T2dm2 | 20.0 | 0 | 1 |
| Tdmq1 | 20.0 | 0 | 1 |
| T2dm2sa | 20.0 | 0 | 1 |
| T2dm1sa | 20.0 | 0 | 1 |
| Life Insurance 2 | 20.0 | 0 | 1 |
| Khuda Buksh | 20.0 | 0 | 1 |
| Suomi Mutual Life Assurance Company | 20.0 | 0 | 1 |
| SunLife | 20.0 | 0 | 1 |
| health data | 20.0 | 0 | 1 |
| Medicinhistoriska museet i Uppsala | 20.0 | 0 | 1 |
| hypertensive disease of pregnancy | 20.0 | 0 | 1 |
| Pacific Mutual Life Insurance Company v. Haslip | 20.0 | 0 | 1 |
| Union Mutual Life Insurance Company v. Kirchoff | 20.0 | 0 | 1 |
| Union Mutual Life Insurance Company v. Kirchoff | 20.0 | 0 | 1 |
| Union Mutual Life Insurance Company v. Kirchoff | 20.0 | 0 | 1 |
| Manhattan Life Insurance Company of New York v. Cohen | 20.0 | 0 | 1 |
| United States v. Atlas Life Insurance Company | 20.0 | 0 | 1 |
| Hartford Life Insurance Company v. Barber | 20.0 | 0 | 1 |
| Hartford Life Insurance Company v. Johnson | 20.0 | 0 | 1 |
| Securities and Exchange Commission v. United Benefit Life Insurance Company | 20.0 | 0 | 1 |
| Securities and Exchange Commission v. Variable Annuity Life Insurance Company of America | 20.0 | 0 | 1 |
| Security Mutual Life Insurance Company v. Prewitt | 20.0 | 0 | 1 |
| Penn Mutual Life Insurance Company v. Austin | 20.0 | 0 | 1 |
| Aetna Life Insurance Company of Hartford Conn v. Haworth | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. Davey | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. Dunken | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. France | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. Moore | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. Moses | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. Patrick C Tremblay | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. Ward | 20.0 | 0 | 1 |
| Hefner v. Northwestern Mutual Life Insurance Company | 20.0 | 0 | 1 |
| United States v. John Hancock Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Helvering v. Midland Mutual Life Insurance Company | 20.0 | 0 | 1 |
| United States v. Kansas City Life Insurance Company | 20.0 | 0 | 1 |
| Her whole Life is an Epigram | 20.0 | 0 | 1 |
| McMaster v. New York Life Insurance Company | 20.0 | 0 | 1 |
| Frederick v. Fidelity Mutual Life Insurance Company of Philadelphia | 20.0 | 0 | 1 |
| American Life Insurance Company v. Mahone | 20.0 | 0 | 1 |
| United States v. Union Central Life Insurance Company | 20.0 | 0 | 1 |
| United States v. Union Central Life Insurance Company | 20.0 | 0 | 1 |
| Slocum v. New York Life Insurance Company | 20.0 | 0 | 1 |
| Metropolitan Life Insurance Company of New York v. New Orleans | 20.0 | 0 | 1 |
| Metropolitan Life Insurance Company v. National Labor Relations Board | 20.0 | 0 | 1 |
| Angle v. North-Western Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Home Life Insurance Company v. Dunn | 20.0 | 0 | 1 |
| Colonial American Life Insurance Company v. Commissioner of Internal Revenue | 20.0 | 0 | 1 |
| Gisborn v. Charter Oak Life Insurance Company of Hartford | 20.0 | 0 | 1 |
| South Carolina ex rel Phoenix Mutual Life Insurance Company v. McMaster | 20.0 | 0 | 1 |
| Connecticut Mutual Life Insurance Company v. Moore | 20.0 | 0 | 1 |
| Bacon v. Northwestern Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Grant v. Phoenix Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Grant v. Phoenix Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Francisco Núñez Olivera | 20.0 | 0 | 1 |
| Mutual Benefit Life Insurance Company v. Tisdale | 20.0 | 0 | 1 |
| Mutual Life Insurance Company of New York v. Hill | 20.0 | 0 | 1 |
| New York Life Insurance Company v. Cravens | 20.0 | 0 | 1 |
| New York Life Insurance Company v. Deer Lodge County | 20.0 | 0 | 1 |
| New York Life Insurance Company v. Dunlevy | 20.0 | 0 | 1 |
| New York Life Insurance Company v. Head | 20.0 | 0 | 1 |
| New York Life Insurance Company v. Head | 20.0 | 0 | 1 |
| Daniel v. Family Security Life Insurance Company | 20.0 | 0 | 1 |
| Bigelow v. Berkshire Life Insurance Company | 20.0 | 0 | 1 |
| Northwestern National Life Insurance Company v. Riggs | 20.0 | 0 | 1 |
| Woodworth v. Northwestern Mutual Life Insurance Company | 20.0 | 0 | 1 |
| Ohio Life Insurance and Trust Company v. Debolt | 20.0 | 0 | 1 |
| Reserve Life Insurance Company v. Bowers | 20.0 | 0 | 1 |
| Ritter v. Mutual Life Insurance Company of New York | 20.0 | 0 | 1 |
| The Story of Life Insurance | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. France | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. Town of Middleport | 20.0 | 0 | 1 |
| Mutual Life Insurance Company of New York v. McGrew | 20.0 | 0 | 1 |
| Mutual Life Insurance Company of New York v. Phinney | 20.0 | 0 | 1 |
| National Labor Relations Board v. Metropolitan Life Insurance Company | 20.0 | 0 | 1 |
| Hinkle v. New England Mutual Life Insurance Company of Boston | 20.0 | 0 | 1 |
| Wright v. Union Central Life Insurance Company | 20.0 | 0 | 1 |
| Aetna Life Insurance Company v. France | 20.0 | 0 | 1 |
| Q19752961 | 20.0 | 0 | 1 |
| TransGlobe Life | 20.0 | 0 | 1 |
| The Life Insurance Company of Virginia | 20.0 | 0 | 1 |
| Lorraine Dennerstein | 20.0 | 0 | 1 |
| Stephen Leeder | 20.0 | 0 | 1 |
| Kotak Life Insurance | 20.0 | 0 | 1 |
| Pradhan Mantri Jeevan Jyoti Bima Yojana | 20.0 | 0 | 1 |
| Momentum Metropolitan Holdings Limited | 20.0 | 0 | 1 |
| Branch 23 Life Insurance | 20.0 | 0 | 1 |
| Medical Museum of Kyushu University | 20.0 | 0 | 1 |
| Universal Life Church Monastery | 20.0 | 0 | 1 |
| Occidental Life Insurance Company Building | 20.0 | 0 | 1 |
| Template:User no exam | 20.0 | 0 | 1 |
| Golden State Mutual Life Insurance Building | 20.0 | 0 | 1 |
| Max S. Freudenberg | 20.0 | 0 | 1 |
| Thai Life Insurance | 20.0 | 0 | 1 |
| AmMetLife | 20.0 | 0 | 1 |
| Golden State Mutual Life Insurance Building | 20.0 | 0 | 1 |
| Q21031128 | 20.0 | 0 | 1 |
| MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus | 20.0 | 0 | 1 |
| Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function | 20.0 | 0 | 1 |
| Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value | 20.0 | 0 | 1 |
| SRY-box transcription factor 13 | 20.0 | 0 | 1 |
| Build-ups in the supply chain of the brain: on the neuroenergetic cause of obesity and type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Low Incidence of Spontaneous Type 1 Diabetes in Non-Obese Diabetic Mice Raised on Gluten-Free Diets Is Associated with Changes in the Intestinal Microbiome | 20.0 | 0 | 1 |
| Passive smoking and risk of type 2 diabetes: a meta-analysis of prospective cohort studies | 20.0 | 0 | 1 |
| Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in Finnish men | 20.0 | 0 | 1 |
| In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells | 20.0 | 0 | 1 |
| Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes | 20.0 | 0 | 1 |
| NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected] | 20.0 | 0 | 1 |
| Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus | 20.0 | 0 | 1 |
| An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials | 20.0 | 0 | 1 |
| Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis | 20.0 | 0 | 1 |
| Levitsky's Insurance Policy; or, When Thief Meets Thief | 20.0 | 0 | 1 |
| First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Lack of an association of miR-938 SNP in IDDM10 with human type 1 diabetes | 20.0 | 0 | 1 |
| Occupational health issues in marine and freshwater research | 20.0 | 0 | 1 |
| Deanna M. Mulligan | 20.0 | 0 | 1 |
| Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal | 20.0 | 0 | 1 |
| Low-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycemic control during 22 months follow-up | 20.0 | 0 | 1 |
| A low-carbohydrate, ketogenic diet to treat type 2 diabetes | 20.0 | 0 | 1 |
| Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting | 20.0 | 0 | 1 |
| Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells | 20.0 | 0 | 1 |
| Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease | 20.0 | 0 | 1 |
| Selection effects may account for better outcomes of the German Disease Management Program for type 2 diabetes | 20.0 | 0 | 1 |
| Incidence of type 2 diabetes in Aboriginal Australians: an 11-year prospective cohort study | 20.0 | 0 | 1 |
| Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes | 20.0 | 0 | 1 |
| Analysis of coding variants in the betacellulin gene in type 2 diabetes and insulin secretion in African American subjects | 20.0 | 0 | 1 |
| Pulmonary fungus ball caused by Penicillium capsulatum in a patient with type 2 diabetes: a case report | 20.0 | 0 | 1 |
| The DiGEM trial protocol--a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659] | 20.0 | 0 | 1 |
| Type 1 diabetes and osteoporosis: from molecular pathways to bone phenotype | 20.0 | 0 | 1 |
| Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease | 20.0 | 0 | 1 |
| M Financial Group | 20.0 | 0 | 1 |
| Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice | 20.0 | 0 | 1 |
| Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits | 20.0 | 0 | 1 |
| Genetic prediction of future type 2 diabetes | 20.0 | 0 | 1 |
| Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays | 20.0 | 0 | 1 |
| Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Beagle Street | 20.0 | 0 | 1 |
| "Metabolic" Surgery for Treatment of Type 2 Diabetes Mellitus | 20.0 | 0 | 1 |
| Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis | 20.0 | 0 | 1 |
| Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians | 20.0 | 0 | 1 |
| Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations | 20.0 | 0 | 1 |
| Type 2 Diabetes | 20.0 | 0 | 1 |
| Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus | 20.0 | 0 | 1 |
| Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future | 20.0 | 0 | 1 |
| Bariatric Surgery in Patients with Type 2 Diabetes: A Viable Option | 20.0 | 0 | 1 |
| Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes | 20.0 | 0 | 1 |
| Mechanism by which metformin reduces glucose production in type 2 diabetes | 20.0 | 0 | 1 |
| Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). | 20.0 | 0 | 1 |
| Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis | 20.0 | 0 | 1 |
| What is Type 1 Diabetes? | 20.0 | 0 | 1 |
| Oral Antidiabetic Agents | 20.0 | 0 | 1 |
| Type 1 Diabetes Mellitus in Pediatrics | 20.0 | 0 | 1 |
| MECHANISMS IN ENDOCRINOLOGY: Seizures and type 1 diabetes mellitus: current state of knowledge | 20.0 | 0 | 1 |
| Sugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk | 20.0 | 0 | 1 |
| Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies | 20.0 | 0 | 1 |
| White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review | 20.0 | 0 | 1 |
| Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial | 20.0 | 0 | 1 |
| Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study | 20.0 | 0 | 1 |
| Obesity: a medical history | 20.0 | 0 | 1 |
| Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | 20.0 | 0 | 1 |
| Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | 20.0 | 0 | 1 |
| Effects of short‐term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo‐controlled trial | 20.0 | 0 | 1 |
| Dietary fats and prevention of type 2 diabetes | 20.0 | 0 | 1 |
| Obesity and labour market success in Finland: The difference between having a high BMI and being fat | 20.0 | 0 | 1 |
| Active Smoking and the Risk of Type 2 Diabetes | 20.0 | 0 | 1 |
| Risk of Fatal and Nonfatal Lactic Acidosis With Metformin Use in Type 2 Diabetes Mellitus | 20.0 | 0 | 1 |
| Detecting Undiagnosed Type 2 Diabetes: Family History as a Risk Factor and Screening Tool | 20.0 | 0 | 1 |
| Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement | 20.0 | 0 | 1 |
| Screening for High Blood Pressure in Adults: U.S. Preventive Services Task Force Recommendation Statement | 20.0 | 0 | 1 |
| Screening for Type 2 Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force | 20.0 | 0 | 1 |
| Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes | 20.0 | 0 | 1 |
| The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance | 20.0 | 0 | 1 |
| The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents | 20.0 | 0 | 1 |
| The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes | 20.0 | 0 | 1 |
| Low Testosterone and the Association With Type 2 Diabetes | 20.0 | 0 | 1 |
| Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure: A Scientific Statement From the American Heart Association | 20.0 | 0 | 1 |
| An Effective Approach to High Blood Pressure Control: A Science Advisory From the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention | 20.0 | 0 | 1 |
| Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association | 20.0 | 0 | 1 |
| Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | 20.0 | 0 | 1 |
| Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes | 20.0 | 0 | 1 |
| Neuropsychological Profiles of Children With Type 1 Diabetes 6 Years After Disease Onset | 20.0 | 0 | 1 |
| Michael Baker | 20.0 | 0 | 1 |
| health in the State of Palestine | 20.0 | 0 | 1 |
| United States Fire Insurance Company | 20.0 | 0 | 1 |
| The Falcon Insurance Public Company Limited | 20.0 | 0 | 1 |
| Metropolitan Life Insurance Company Hall of Records | 20.0 | 0 | 1 |
| Mismatch of sleep and work timing and risk of type 2 diabetes | 20.0 | 0 | 1 |
| Is NF-kappaB a culprit in type 2 diabetes? | 20.0 | 0 | 1 |
| Health Conditions as Mediators of the Association Between World Trade Center Exposure and Health-Related Quality of Life in Firefighters and EMS Workers | 20.0 | 0 | 1 |
| Identifying priority health conditions, environmental data, and infrastructure needs: a synopsis of the Pew Environmental Health Tracking Project | 20.0 | 0 | 1 |
| Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics | 20.0 | 0 | 1 |
| An overview of 9/11 experiences and respiratory and mental health conditions among World Trade Center Health Registry enrollees | 20.0 | 0 | 1 |
| Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987-1998 | 20.0 | 0 | 1 |
| Children's health and the environment: public health issues and challenges for risk assessment | 20.0 | 0 | 1 |
| The National Institute for Occupational Safety and Health indoor environmental evaluation experience. Part three: associations between environmental factors and self-reported health conditions | 20.0 | 0 | 1 |
| Work organization and health issues in long-term care centers: comparison of perceptions between caregivers and management | 20.0 | 0 | 1 |
| High Blood Pressure & Cardiovascular Prevention | 20.0 | 0 | 1 |
| .lifeinsurance | 20.0 | 0 | 1 |
| Northern States Life Insurance Company | 20.0 | 0 | 1 |
| Category:Life insurance in India | 20.0 | 0 | 1 |
| Knowledge of medical history information among proxy respondents for deceased study subjects | 20.0 | 0 | 1 |
| Dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Interventions for the prevention of type 2 diabetes mellitus in women with previous gestational diabetes | 20.0 | 0 | 1 |
| Self management interventions for type 2 diabetes in adult people with severe mental illness | 20.0 | 0 | 1 |
| Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for development of type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Acupuncture for adults with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Dietary advice for the prevention of type 2 diabetes mellitus in adults | 20.0 | 0 | 1 |
| Sulphonylurea monotherapy for patients with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Yoga for adults with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Group based diabetes self-management education compared to routine treatment, waiting list control or no intervention for people with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Metformin monotherapy for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Personalised care planning for adults with chronic or long-term health conditions | 20.0 | 0 | 1 |
| Pioglitazone for adults with high risk of developing type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Continuous glucose monitoring systems for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Herbal medicines for type 1 diabetes mellitus | 20.0 | 0 | 1 |
| Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance | 20.0 | 0 | 1 |
| Mulberry therapy for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Resveratrol for treatment of type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Self-management interventions for type 2 diabetes in adult people with severe mental illness | 20.0 | 0 | 1 |
| Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Ultra-long acting insulin versus long-acting insulin for type 1 diabetes mellitus | 20.0 | 0 | 1 |
| Family based interventions for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Fibrates for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Probucol for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Extended-release metformin versus immediate-release metformin for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Physical exercise for type 1 diabetes mellitus | 20.0 | 0 | 1 |
| Sulphonylurea monotherapy for patients with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance | 20.0 | 0 | 1 |
| Acupuncture for adults with type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Sweet potato for type 2 diabetes mellitus | 20.0 | 0 | 1 |
| Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus | 20.0 | 0 | 1 |